Hoyle Cohen, LLC Eli Lilly & CO Transaction History

Hoyle Cohen, LLC

$1.31 Billion
Q2 2024

A detailed history of Hoyle Cohen, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hoyle Cohen, LLC holds 5,380 shares of LLY stock, worth $4.02 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

5,380

Previous 5,442 1.14%

Holding current value

$4.02 Million

Previous $4.23 Million 15.05%

% of portfolio

0.37%

Previous 0.33%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $44,941 - $56,360	-62 Reduced 1.14%	5,380 $4.87 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $44,415 - $59,421	-75 Reduced 1.36%	5,442 $4.23 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $51,993 - $61,293	99 Added 1.83%	5,517 $3.22 Million
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $33,471 - $46,146	-77 Reduced 1.4%	5,418 $2.91 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $118,550 - $158,515	-338 Reduced 5.79%	5,495 $2.58 Million
Q1 2023 May 05, 2023	BUY	$310.63 - $364.82 $4,348 - $5,107	14 Added 0.24%	5,833 $2 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $22,508 - $26,226	-70 Reduced 1.19%	5,819 $2.13 Million
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $1,482 - $1,689	5 Added 0.08%	5,889 $1.9 Million
Q2 2022 Jul 27, 2022	SELL	$278.73 - $327.27 $27,594 - $32,399	-99 Reduced 1.65%	5,884 $1.91 Million
Q1 2022 May 03, 2022	BUY	$234.69 - $291.66 $49,519 - $61,540	211 Added 3.66%	5,983 $1.71 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $24,733 - $30,694	110 Added 1.94%	5,772 $1.59 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $97,504 - $119,992	-440 Reduced 7.21%	5,662 $1.31 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $3,611 - $4,670	-20 Reduced 0.33%	6,102 $1.4 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $35,986 - $46,585	219 Added 3.71%	6,122 $1.14 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $67,186 - $88,904	-515 Reduced 8.02%	5,903 $997,000
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $3,947 - $4,566	27 Added 0.42%	6,418 $950,000
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $7,143 - $8,841	-60 Reduced 0.93%	6,391 $887,000
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $4,383 - $5,429	41 Added 0.64%	6,451 $848,000
Q3 2019 Nov 15, 2019	BUY	$106.79 - $116.16 $5,339 - $5,808	50 Added 0.79%	6,410 $717,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $29,016 - $32,507	274 Added 4.5%	6,360 $736,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $7,383 - $9,228	86 Added 1.43%	6,086 $653,000
Q2 2018 Aug 06, 2018	BUY	$75.7 - $86.88 $454,200 - $521,280	6,000 New	6,000 $512,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoyle Cohen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hoyle Cohen, LLC with notifications on news.

Account